All In Biotech

Drug Trial Radar · NCT02116335

Endothelin Receptor Function and Acute Stress

Endothelin Receptor Function and Acute Stress (End-Stress)

Last checked: Nov 20, 2026Latest source record: Jan 28, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingRandomized with 320 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

320

Planned (sponsor's estimate)

Start

Jun 2015

Primary completion

Dec 2025

Study completion Jan 2026

Sponsor

Lead sponsor
Augusta UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
First posted
Apr 16, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Crossover
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 50 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Our bodies respond differently to stress. Animal studies by the investigators have found that endothelin-1 plays a role in regulating blood pressure in response to stress. This study is an extension of the investigators previous animal work to evaluate the role of endothelin-1 during stress in humans.

Conditions

  • Hypertension

Interventions

  • BosentanDrug

    Stress response and vascular function will be assessed 3 days following 125 mg twice per day of Bosentan

  • PlaceboDrug

    Stress response and vascular function will be assessed 3 days following twice per day placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Flow-Mediated Dilation (FMD)Time frame: Baseline and 3 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Georgia Regents University

    Augusta, Georgia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.